Neurology: Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study
Conference Summary
Neurology: Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study is organized by American Academy of Neurology (AAN).
Released: 1/23/2018
Expires: 1/23/2021
Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Learning Objectives:
Upon completion of the article by Hernandez-Diaz et al, the participant should be able to:
• State differences between women taking topiramate and women unexposed to topiramate in this study
• Discuss the relative risk of oral clefts in infants exposed to topiramate in this study compared to infants who were unexposed or exposed to lamotrigine
• Discuss factors which increased the risk of oral clefts in infants exposed to topiramate
Credit Info
- CME : 0.75
Author (s)
2 Speakers
Target Audience
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
Peers Info
Number of Health Care Professionals Registered: 1 Number
Browse CME / CE Conferences by Specialty View All
- Cardiology
- Clinical Pharmacology
- Dentistry
- Dermatology
- Emergency Medicine
- Endocrinology
- Endocrinology, Metabolism and Diabetes
- Gastroenterology
- Haematology
- Healthcare Management
- Infectious Disease
- Medical Education
- Medicine
- Neurology
- Nursing
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Pain Management
- Pediatrics
- Pharmacy and Medicine
- Primary Care
- Psychiatry
- Psychology
- Pulmonary Medicine
- Radiology
- Rheumatology
- Surgery